(VIANEWS) – Pinduoduo (PDD), Simmons First National Corporation (SFNC), Alexandria Real Estate Equities (ARE) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Pinduoduo (PDD)
32.2% sales growth and 25.36% return on equity
Pinduoduo Inc., through its subsidiaries, operates an e-commerce platform in the People's Republic of China. It operates Pinduoduo, a mobile platform that offers a range of products, including apparel, shoes, bags, mother and childcare products, food and beverages, fresh produce, electronic appliances, furniture and household goods, cosmetics and other personal care items, sports and fitness items, and auto accessories. The company was formerly known as Walnut Street Group Holding Limited and changed its name to Pinduoduo Inc. in July 2018. Pinduoduo Inc. was incorporated in 2015 and is headquartered in Shanghai, the People's Republic of China.
Earnings Per Share
As for profitability, Pinduoduo has a trailing twelve months EPS of $-0.93.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.36%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 36.4%, now sitting on 103.97B for the twelve trailing months.
2. Simmons First National Corporation (SFNC)
31.7% sales growth and 7.16% return on equity
Simmons First National Corporation operates as the holding company for Simmons Bank that provides banking and other financial products and services to individuals and businesses. It offers checking, savings, and time deposits; consumer, real estate, and commercial loans; agricultural finance, equipment, and small business administration lending; trust and fiduciary services; credit cards; investment management products; insurance products; and securities and investment services. The company also provides ATM services; Internet and mobile banking platforms; overdraft facilities; and safe deposit boxes. As of January 27, 2022, the company operated through 199 financial centers in Arkansas, Missouri, Tennessee, Texas, Oklahoma, and Kansas. Simmons First National Corporation was founded in 1903 and is headquartered in Pine Bluff, Arkansas.
Earnings Per Share
As for profitability, Simmons First National Corporation has a trailing twelve months EPS of $2.25.
PE Ratio
Simmons First National Corporation has a trailing twelve months price to earnings ratio of 10.36. Meaning, the purchaser of the share is investing $10.36 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.16%.
Moving Average
Simmons First National Corporation’s worth is higher than its 50-day moving average of $21.90 and above its 200-day moving average of $23.07.
Revenue Growth
Year-on-year quarterly revenue growth grew by 10.6%, now sitting on 835.35M for the twelve trailing months.
Sales Growth
Simmons First National Corporation’s sales growth is 35.3% for the present quarter and 31.7% for the next.
Yearly Top and Bottom Value
Simmons First National Corporation’s stock is valued at $23.29 at 00:22 EST, way below its 52-week high of $29.41 and way higher than its 52-week low of $19.34.
3. Alexandria Real Estate Equities (ARE)
12.3% sales growth and 3.53% return on equity
Alexandria Real Estate Equities, Inc. (NYSE:ARE), an S&P 500<sup>®</sup> urban office real estate investment trust ("REIT"), is the first, longest-tenured, and pioneering owner, operator, and developer uniquely focused on collaborative life science, technology, and agtech campuses in AAA innovation cluster locations, with a total market capitalization of $31.9 billion as of December 31, 2020, and an asset base in North America of 49.7 million square feet ("SF"). The asset base in North America includes 31.9 million RSF of operating properties and 3.3 million RSF of Class A properties undergoing construction, 7.1 million RSF of near-term and intermediate-term development and redevelopment projects, and 7.4 million SF of future development projects. Founded in 1994, Alexandria pioneered this niche and has since established a significant market presence in key locations, including Greater Boston, San Francisco, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a longstanding and proven track record of developing Class A properties clustered in urban life science, technology, and agtech campuses that provide our innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science, technology, and agtech companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.
Earnings Per Share
As for profitability, Alexandria Real Estate Equities has a trailing twelve months EPS of $5.74.
PE Ratio
Alexandria Real Estate Equities has a trailing twelve months price to earnings ratio of 28.16. Meaning, the purchaser of the share is investing $28.16 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.53%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 59.6% and 186.5%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth grew by 19.8%, now sitting on 2.5B for the twelve trailing months.
Yearly Top and Bottom Value
Alexandria Real Estate Equities’s stock is valued at $161.58 at 00:22 EST, way under its 52-week high of $206.85 and way higher than its 52-week low of $126.74.
4. Sensus Healthcare (SRTS)
5.1% sales growth and 65.45% return on equity
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
Earnings Per Share
As for profitability, Sensus Healthcare has a trailing twelve months EPS of $1.53.
PE Ratio
Sensus Healthcare has a trailing twelve months price to earnings ratio of 4.78. Meaning, the purchaser of the share is investing $4.78 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 65.45%.
Yearly Top and Bottom Value
Sensus Healthcare’s stock is valued at $7.32 at 00:22 EST, way below its 52-week high of $15.25 and way above its 52-week low of $5.58.
Sales Growth
Sensus Healthcare’s sales growth is negative 2% for the present quarter and 5.1% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 0.6%, now sitting on 44.53M for the twelve trailing months.
